vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and BRINKS CO (BCO). Click either name above to swap in a different company.
BRINKS CO is the larger business by last-quarter revenue ($1.4B vs $829.0M, roughly 1.7× Acadia Healthcare Company, Inc.). BRINKS CO runs the higher net margin — 4.9% vs 0.5%, a 4.4% gap on every dollar of revenue. On growth, BRINKS CO posted the faster year-over-year revenue change (9.1% vs 7.5%). Over the past eight quarters, BRINKS CO's revenue compounded faster (5.6% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
The Brink's Company is an American cash handling company, headquartered in Richmond, Virginia. Its operations include cash-in-transit, ATM replenishment & maintenance, and cash management & payment services, such as vault outsourcing, money processing, intelligent safe services, and international transportation of valuables.
ACHC vs BCO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $1.4B |
| Net Profit | $4.5M | $68.1M |
| Gross Margin | — | 27.7% |
| Operating Margin | — | 13.1% |
| Net Margin | 0.5% | 4.9% |
| Revenue YoY | 7.5% | 9.1% |
| Net Profit YoY | -50.8% | 76.9% |
| EPS (diluted) | $0.05 | $1.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.4B | ||
| Q3 25 | $851.6M | $1.3B | ||
| Q2 25 | $869.2M | $1.3B | ||
| Q1 25 | $770.5M | $1.2B | ||
| Q4 24 | $774.2M | $1.3B | ||
| Q3 24 | $815.6M | $1.3B | ||
| Q2 24 | $796.0M | $1.3B |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $68.1M | ||
| Q3 25 | $36.2M | $36.3M | ||
| Q2 25 | $30.1M | $43.7M | ||
| Q1 25 | $8.4M | $51.6M | ||
| Q4 24 | $32.6M | $38.5M | ||
| Q3 24 | $68.1M | $28.9M | ||
| Q2 24 | $78.5M | $46.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 27.7% | ||
| Q3 25 | — | 25.8% | ||
| Q2 25 | — | 24.9% | ||
| Q1 25 | — | 24.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 25.0% | ||
| Q2 24 | — | 25.2% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 13.1% | ||
| Q3 25 | 4.7% | 11.4% | ||
| Q2 25 | 5.8% | 10.3% | ||
| Q1 25 | 1.7% | 9.6% | ||
| Q4 24 | 4.9% | 8.3% | ||
| Q3 24 | 12.1% | 8.9% | ||
| Q2 24 | 13.4% | 9.3% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 4.9% | ||
| Q3 25 | 4.3% | 2.7% | ||
| Q2 25 | 3.5% | 3.4% | ||
| Q1 25 | 1.1% | 4.1% | ||
| Q4 24 | 4.2% | 3.0% | ||
| Q3 24 | 8.4% | 2.3% | ||
| Q2 24 | 9.9% | 3.7% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.62 | ||
| Q3 25 | $0.40 | $0.86 | ||
| Q2 25 | $0.33 | $1.03 | ||
| Q1 25 | $0.09 | $1.18 | ||
| Q4 24 | $0.36 | $0.87 | ||
| Q3 24 | $0.74 | $0.65 | ||
| Q2 24 | $0.85 | $1.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $1.7B |
| Total DebtLower is stronger | $2.5B | $4.0B |
| Stockholders' EquityBook value | $2.0B | $277.7M |
| Total Assets | $5.5B | $7.3B |
| Debt / EquityLower = less leverage | 1.29× | 14.31× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $1.7B | ||
| Q3 25 | $118.7M | $1.3B | ||
| Q2 25 | $131.4M | $1.4B | ||
| Q1 25 | $91.2M | $1.2B | ||
| Q4 24 | $76.3M | $1.4B | ||
| Q3 24 | $82.1M | $1.2B | ||
| Q2 24 | $77.2M | $1.2B |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $4.0B | ||
| Q3 25 | $2.3B | $3.8B | ||
| Q2 25 | $2.3B | $3.9B | ||
| Q1 25 | $2.2B | $3.7B | ||
| Q4 24 | $2.0B | $3.7B | ||
| Q3 24 | $1.9B | $3.7B | ||
| Q2 24 | $1.8B | $3.6B |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $277.7M | ||
| Q3 25 | $3.1B | $268.5M | ||
| Q2 25 | $3.1B | $254.6M | ||
| Q1 25 | $3.0B | $205.8M | ||
| Q4 24 | $3.1B | $184.9M | ||
| Q3 24 | $3.0B | $277.1M | ||
| Q2 24 | $3.0B | $320.5M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $7.3B | ||
| Q3 25 | $6.4B | $7.0B | ||
| Q2 25 | $6.3B | $7.1B | ||
| Q1 25 | $6.1B | $6.6B | ||
| Q4 24 | $6.0B | $6.6B | ||
| Q3 24 | $5.9B | $6.7B | ||
| Q2 24 | $5.7B | $6.6B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 14.31× | ||
| Q3 25 | 0.74× | 14.05× | ||
| Q2 25 | 0.74× | 15.48× | ||
| Q1 25 | 0.72× | 18.19× | ||
| Q4 24 | 0.64× | 20.26× | ||
| Q3 24 | 0.62× | 13.39× | ||
| Q2 24 | 0.62× | 11.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 3.5% |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | — | ||
| Q3 25 | $73.2M | $122.1M | ||
| Q2 25 | $133.5M | — | ||
| Q1 25 | $11.5M | $-60.2M | ||
| Q4 24 | $116.7M | $369.8M | ||
| Q3 24 | $163.1M | $58.4M | ||
| Q2 24 | $171.1M | $-66.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | $77.4M | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | $-119.1M | ||
| Q4 24 | $-86.8M | $307.2M | ||
| Q3 24 | $-27.1M | $7.4M | ||
| Q2 24 | $16.9M | $-122.8M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | 5.8% | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | -9.6% | ||
| Q4 24 | -11.2% | 24.3% | ||
| Q3 24 | -3.3% | 0.6% | ||
| Q2 24 | 2.1% | -9.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 3.5% | ||
| Q3 25 | 16.0% | 3.3% | ||
| Q2 25 | 19.3% | 4.0% | ||
| Q1 25 | 22.7% | 4.7% | ||
| Q4 24 | 26.3% | 5.0% | ||
| Q3 24 | 23.3% | 4.1% | ||
| Q2 24 | 19.4% | 4.5% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | 3.36× | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | -1.17× | ||
| Q4 24 | 3.58× | 9.61× | ||
| Q3 24 | 2.39× | 2.02× | ||
| Q2 24 | 2.18× | -1.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
BCO
Segment breakdown not available.
